Ligand validation:8CFX

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8CFX_NAD_D_501	90%	68%	0.095	0.977	0.53	0.69	-	1	0	0	100%	1
8CFX_NAD_J_501	89%	67%	0.097	0.976	0.55	0.71	-	1	0	0	100%	1
8CFX_NAD_I_501	86%	69%	0.092	0.959	0.52	0.68	-	1	1	0	100%	1
8CFX_NAD_H_501	85%	68%	0.099	0.965	0.54	0.68	-	1	0	0	100%	1
8CFX_NAD_A_501	84%	68%	0.108	0.971	0.52	0.72	-	1	0	0	100%	1
8CFX_NAD_G_501	84%	68%	0.116	0.979	0.56	0.69	-	1	0	0	100%	1
8CFX_NAD_C_501	82%	68%	0.1	0.954	0.56	0.68	-	1	0	0	100%	1
8CFX_NAD_B_501	81%	68%	0.116	0.97	0.53	0.71	-	1	0	0	100%	1
8CFP_NAD_C_501	99%	64%	0.045	0.984	0.58	0.8	-	1	0	0	100%	1
8CFU_NAD_A_501	99%	64%	0.05	0.988	0.58	0.79	-	1	0	0	100%	1
6F3Q_NAD_C_504	99%	52%	0.053	0.989	0.8	1.04	1	2	0	0	100%	1
8CFS_NAD_C_501	99%	64%	0.05	0.982	0.57	0.8	-	1	1	0	100%	1
8CFV_NAD_C_501	99%	67%	0.055	0.986	0.55	0.73	-	1	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	16%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.